Inflammatory status is associated with outcome in oral squamous cell carcinoma (OSCC). Combining the preoperative neutrophil to lymphocyte ratio (NLR) and histopathologic features may provide clinicians with more exact information regarding the prognosis of OSCC.
O ral squamous cell carcinoma (OSCC) is one of the most frequent malignant tumors worldwide, with an increasing incidence in Taiwan and some areca quiduse areas. 1 Despite improved therapeutic strategies, such as diagnostic workup, surgical techniques, chemotherapy, and radiotherapy, outcomes for patients with OSCC remain unchanged during the past decade. 2, 3 Prognosis of patients with OSCC and treatment considerations depend mostly on the American Joint Committee on Cancer (AJCC) TNM classification. However, the current TNM staging is not precise enough to estimate outcomes because it focuses on only the tumor itself. Patients with the same stage often have different outcomes. Therefore, it is important to improve and adjust the present TNM staging system to identify patients with poor prognosis or at high risk of disease recurrence and death. 4 A previous study 5 found that inflammatory status has a prognostic role in cancer pathogenesis and disease progression. The neutrophil to lymphocyte ratio (NLR) is a systemic inflammatory response marker that has been studied as an independent prognostic factor in head and neck cancers. [6] [7] [8] The NLR can be measured conveniently, is cost-effective and easily reproducible, may allow widespread clinical use, and can contribute to prognosis estimation. Therefore, as opposed to the TNM staging system that is solely based on anatomical information and does not reflect the biological heterogeneity of cancers, adding an inflammatory biomarker into the TNM classification may complement prognosis estimation for patients with OSCC.
The prognostic values of the NLR have been assessed in patients with OSCC, but a previous study 7 considered only serum inflammatory biomarkers. As previously known, traditional histopathologic prognostic factors, including tumor thickness, grade, extracapsular spread, margin status, and perineural invasion (PNI), have been routinely used to estimate outcomes for patients with OSCC in the literature. [9] [10] [11] Combining NLR and pathologic tumor characteristics may provide clinicians more exact information regarding the prognosis of OSCC. Given this background, we revised the routinely used TNM staging system by incorporating histopathologic features and the NLR to produce a new staging category. The aim of this study was not only to evaluate factors associated with OSCC survival but also to assess whether this new staging category with the addition of the NLR and histopathologic features to the current TNM system-based prediction models improved the discrimination of 5-year disease-specific survival (DSS).
Methods

Ethics Statement
This study was reviewed and approved by the institutional review board of Kaohsiung Veterans General Hospital in Taiwan. The requirement for informed consent was waived because all identifying information was removed from the data set before analysis.
Database and Patient Demographics
The data for this study were collected from the cancer registry data set from the Kaohsiung Veterans General Hospital Can- 4 The clinical end point was 5-year DSS rate. Deaths because of cancer were recorded as events, and deaths secondary to other causes were censored.
Laboratory Assays
Routine complete blood cell counts and differential cell counts were routinely collected as part of a preoperative protocol. The analysis was performed within 30 days of the surgery, and if multiple values existed for a patient, sample values closest to the date of resection were selected. Patients with any signs of infection or who were administered corticosteroids or immunosuppressive medications were excluded from the analysis. The NLR was defined as the absolute neutrophil count divided by the absolute lymphocyte count. A consensus of the NLR cutoff value for OSCC remains to be determined. In this analysis, we tested the use of different sets of cutoff points, and we adapted the cutoff points (median, 2.37) instead of using the receiver operating characteristic curve cutoff value of 3.41 to define high and low NLR groups because of its better discriminability ( Table 1) .
estimates of the coefficients for the selected model and to develop an integer scoring system by following methods used in the Framingham study. 12 The β coefficients from the Cox proportional hazards regression model were used to develop an 
Statistical Analysis
Continuous variables were analyzed with 1-way analysis of variance, and categorical variables were compared by Pearson χ 2 or Fisher exact test. Cumulative 5-year DSS rates for the AJCC staging system and new staging category were analyzed using the Kaplan-Meier method. Survival curves were measured from the time of diagnosis using disease-specific mortality as the primary event variable. Proportional hazards assumption was met for all variables. The Cox proportional hazards regression model was used to compare the 5-year DSS rates for these 2 stage systems after adjusting for clinicopathologic factors. Monotonicity was also assessed with linear trend χ 2 test, and a higher value indicated a better monotonic trend. 13, 14 Discriminability of a gradient evaluation for the AJCC staging system and new staging category were assessed with the Akaike information criterion (AIC) 15 and Harrell C statistic. In addition, a model with a lower AIC was preferred to reduce the risk of overfitting. The Harrell C statistic indicated model prediction as follows: 0.5, equal chance; 0.7 to 0.8, acceptable; 0.8 to 0.9, excellent; and 0.9 to 1, outstanding. SPSS statistical software, version 15 (SPSS Inc), was used for analysis, P < .05 was used to determine statistical significance, and all tests were 2-sided.
Results
In total, 396 patients who underwent major surgery with curative intent for oral cancer with or without adjuvant therapy were included in this study ( Abbreviations: aHR, adjusted hazard ratio; NLR, neutrophil to lymphocyte ratio.
Research Original Investigation Prognostic Performance of a New Staging Category for Oral Cancer Survival Prediction Discussion
In this study, we confirmed that a high preoperative NLR was significantly associated with poor DSS in patients with OSCC, and we attempted to use and test the prognostic utility of combining the NLR, histopathologic features, and pathologic T and N classifications to create a new staging category. The present TNM staging is deficient in estimating survival outcomes in OSCC, and incorporation of the NLR and PNI into a prognostic model based on the TNM classification significantly improved risk reclassification for disease-specific survival. Thus, this new staging category could help to stratify high-risk patients who may benefit from more intense adjuvant therapy. This study had several strengths. To our knowledge, this is the first study to merge both the NLR and histopathologic features into a new risk category for patients with OSCC. Second, pathologic TNM staging does not consider other clinically or pathologically relevant factors, such as inflammatory status and differentiation or PNI profile for a tumor. This new risk category improves discriminability and monotonicity relative to the current pathologic TNM staging because it has the strengths of the NLR and histopathologic features and eliminates drawbacks with pathologic TNM staging. Third, our study provided a new staging category that is easy to use for patients with early-or advanced-stage OSCC. For patients with OSCC undergoing surgical intervention, risk stratification considering tumor size, location, involved lymph nodes, histopathologic features, and inflammatory status is sufficient to estimate survival.
Despite recent improvements in the identification of genetic and molecular factors in OSCC, 16 ,17 the most widely used routine prognostic assessment of OSCC still relies on traditional histopathologic features, such as tumor size, involved lymph node status, extracapsular spread, surgical margin, differentiation, and PNI. 9 However, there is increasing evidence regarding the involvement of inflammation and activation of the immune system in carcinogenesis, tumor growth, invasion, and metastasis. 5, 18, 19 This systemic inflammatory response leads to changes in relative levels of circulating leukocytes, including neutrophils, macrophages, eosinophils, and lymphocytes. Neutrophils in the tumor microenvironment stimulate tumor development by producing cytokines and chemokines, such as vascular endothelial growth factor, interleukin 6, and tumor necrosis factor. 20 Lymphocytes are also crucial components in the adaptive immune system, and infiltrating lymphocytes have been reported to indicate the generation of an effective antitumor cellular immune response. Furthermore, an in vitro study 21 found that the cytolytic activity of lymphocytes and natural killer cells was suppressed by neutrophils. Thus, a low peripheral lymphocyte level may reflect a poorer lymphocyte-mediated immune response against a tumor and suggests a worse prognosis. 22 Therefore, in this study, we selected the most commonly used inflammatory marker NLR, which explained the balance between protumor inflammatory status and antitumor immune response. Zahorec 23 was the first to propose the NLR as a rapid and simple index to assess systemic inflammatory response in 90 oncologic patients in an intensive care unit. In contrast to other inflammatory markers, it is inexpensive and easily accessible. It also comprises components within the routine full blood cell count assay and can be performed easily before major surgery. A higher NLR is related to poor prognosis in many cancers, such as ovarian cancer, 22 several digestive system cancers, 24,25 lung cancer, 26 and prostate cancer. 27 To our knowledge, evidence regarding the use of the NLR as an outcome estimator for patients with head and neck cancer is limited. Haddad et al 28 found
that an NLR of 5 or greater was a prognostic factor for locally advanced head and neck cancer for 2-year overall survival (P = .02) and metastasis-free survival (P = .08). Perisanidis et al 7 also reported that an elevated NLR was significant, with a shorter DSS in patients with oral cancer who were administered preoperative chemoradiotherapy (HR, 10.37; 95% CI, 1.28-84.08; P = .03). In addition, a consensus regarding the NLR cutoff value remains to be determined. In our study, NLR (median value of NLR, >2.37) was significantly associated with poor outcome, similar to previous reports. 7, 8 In the multivariate Cox proportional hazards regression analysis given in Currently, management of OSCC is still based on the pathologic TNM staging of patient specimens. However, cancer staging based on the TNM system is considered imperfect in estimating survival, and large numbers of histopathologic, immunohistochemical, and molecular biomarkers have been reported in the literature. 29 Better prognostic tools that combine important clinical and pathologic factors to estimate outcome are needed. The present study assesses the effectiveness of tumor characteristics and the NLR in estimating the survival of patients with OSCC after major surgery. The purpose was to group patients into a high-risk category who would benefit from more intense therapy and a low-risk category in 
Conclusions
The present study found that a high NLR and PNI were independent prognostic factors for patients with OSCC after major surgery and that integration of the NLR and PNI into a pathologic TNM classification-based group can complement and improve the accuracy of survival estimation. This new staging category could be used to further stratify patients with OSCC and help identify low-risk patients for intensive follow-up and high-risk patients for adoption of personal adjuvant therapy.
